FMR CORP 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-12 09:55 am Sale |
2024-11-08 | 13G | Edgewise Therapeutics, Inc. EWTX |
FMR CORP | 653,207 0.696% |
-4,127,355 (-86.34%) |
Filing |
| 2024-07-10 10:10 am Sale |
2024-07-09 | 13G | Edgewise Therapeutics, Inc. EWTX |
FMR CORP | 4,780,562 5.118% |
-1,711,951 (-26.37%) |
Filing |
| 2024-02-09 09:03 am Sale |
2024-02-08 | 13G | Edgewise Therapeutics, Inc. EWTX |
FMR CORP | 6,492,513 10.230% |
-2,096,716 (-24.41%) |
Filing |
| 2023-02-09 10:59 am Purchase |
2023-02-09 | 13G | Edgewise Therapeutics, Inc. EWTX |
FMR CORP | 8,589,229 13.587% |
612,416 (+7.68%) |
Filing |
| 2022-10-11 09:03 am Purchase |
2022-10-07 | 13G | Edgewise Therapeutics, Inc. EWTX |
FMR CORP | 7,976,813 12.631% |
5,476,714 (+219.06%) |
Filing |
| 2022-02-09 09:11 am Purchase |
2022-02-08 | 13G | Edgewise Therapeutics, Inc. EWTX |
FMR CORP | 2,500,099 5.071% |
2,500,099 (New Position) |
Filing |